Physician profile
Jodine E Messina
NPI 1770881476
$468.50
in general payments reported to CMS, 2019-2025
14 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.49 · 2022: $51.80 · 2023: $40.84 · 2024: $147 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $83.20 | 2024-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $64.67 | 2022-2024 | Freestyle Libre 3 |
| Abbvie INC. | $44.62 | 2022-2025 | |
| Hologic Sales and Service, LLC | $44.44 | 2024-2025 | Aptima |
| Vanda Pharmaceuticals INC. | $39.99 | 2025 | Fanapt |
| Corcept Therapeutics | $38.89 | 2025 | Korlym |
| Exact Sciences Corporation | $29.16 | 2024 | Cologuard Collection Kit |
| Braeburn INC. | $23.61 | 2025 | Brixadi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.36 | 2024 | Caplyta |
| Gilead Sciences, INC. | $18.48 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $17.69 | 2025 | Breztri |
| Teva Pharmaceuticals USA, INC. | $16.49 | 2021 | |
| Amgen INC. | $14.45 | 2022 | |
| Glaxosmithkline, LLC. | $13.45 | 2023 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodine Messina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.